Patents by Inventor Erik S. G. Stroes

Erik S. G. Stroes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of endothelial dysfunction in diabetic patients
    Patent number: 8557962
    Abstract: A method for the treatment of endothelial dysfunction in a diabetic patient, including both diabetes induced macrovascular disorders and diabetes induced microvascular disorders, comprises administration, preferably parenteral administration, to the patient of an effective amount of high density lipoprotein (HDL).
    Type: Grant
    Filed: January 31, 2011
    Date of Patent: October 15, 2013
    Assignee: CSL Limited
    Inventor: Erik S. G. Stroes
  • TREATMENT OF ENDOTHELIAL DYSFUNCTION IN DIABETIC PATIENTS
    Publication number: 20110190193
    Abstract: A method for the treatment of endothelial dysfunction in a diabetic patient, including both diabetes induced macrovascular disorders and diabetes induced microvascular disorders, comprises administration, preferably parenteral administration, to the patient of an effective amount of high density lipoprotein (HDL).
    Type: Application
    Filed: January 31, 2011
    Publication date: August 4, 2011
    Inventor: Erik S.G. Stroes
  • Treatment of endothelial dysfunction in diabetic patients
    Patent number: 7956035
    Abstract: A method for the treatment of endothelial dysfunction in a diabetic patient, including both diabetes induced macrovascular disorders and diabetes induced microvascular disorders, comprises administration, preferably parenteral administration, to the patient of an effective amount of high density lipoprotein (HDL).
    Type: Grant
    Filed: March 1, 2007
    Date of Patent: June 7, 2011
    Assignee: CSL Limited
    Inventor: Erik S. G. Stroes
  • Treatment of endothelial dysfunction in diabetic patients
    Publication number: 20080214434
    Abstract: A method for the treatment of endothelial dysfunction in a diabetic patient, including both diabetes induced macrovascular disorders and diabetes induced microvascular disorders, comprises administration, preferably parenteral administration, to the patient of an effective amount of high density lipoprotein (HDL).
    Type: Application
    Filed: March 1, 2007
    Publication date: September 4, 2008
    Applicant: CSL Limited
    Inventor: Erik S.G. Stroes